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Terminalia bellirica Roxb., known as Bahera or Beleric or bastard myrobalan, belonging to the family Combretaceae of order 
Rosales, is a large deciduous tree common on plains and lower hills in Southeast Asia, where it is also grown as an avenue tree. 
Glucoside, tannins, gallic acid, ellagic acid, ethyl galate, gallyl glucose, chebulanic acid are the main active phytoconstituents of 
medicinal importance. These phytoconstituents are responsible for many of the pharmacological roles. Different parts of the tree 
have various medicinal activities viz., antisecretory, analgesic, antihypertensive, antidiarrhoeal activity, antimicrobial activity 
antidiabetic, antioxidant, antiulcer, antipyretic, hepatoprotective, anticancer, angiogenesis, antidepressant-like and anti-urolithiatic 
activity. This affects the LDL oxidation and macrophage inflammatory response and also nephrotoxic effects. Also having 
antipsychotic potential helpful in preventing delaying clot formation and have immunostimulant activity. Their traditional uses 
include relief in a cough, asthma, indigestion, dental problems, sore throat and wounds. The review also records some tissue culture 
investigations made for micropropagation and genetic diversity of T. bellirica. 
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Introduction 
Medicinal plants have been used in all cultures as a 
source of medicine since times immemorial. Herbal 
medicine is still the mainstay of health care in several 
developing countries. The World Health Organization 
has estimated that more than 80 % of the world’s 
population in developing countries depends primarily 
on herbal medicine for basic healthcare needs1. 
Terminalia bellirica Roxb. is a large tree, up to 40 m 
high. Leaves are petiolate, broadly elliptic, clustered 
towards the end of branches. Flowers are greenish 
yellow, in solitary, simple, axillary spikes. T. bellirica 
is found in deciduous forests throughout the greater 
part of India, but not in the arid regions, in upper 
Gangetic plains, Chota Nagpur, Bihar, Orissa, West 
Bengal, Konkan, Deccan and most of South India2,3. 
The common name Bahera or Bhaira is based on 
the Hindi name of the tree. The word Bellirica is 
taken from the scientific name of the tree and 
distinguishes this myrobalan from the other one 
(Chebulic myrobalan)4. It is the secondary host of 
tasar silkworm5. T. bellirica is known as–Vibhitaka, 
Vibhitaki in Sanskrit, Belliric myrobalan in English, 
in Tamil‐Tanni, Tanrikkai, in Punjabi‐ Bahera, Birha. 
T. bellirica contains different chemical constituents 
in different parts such as stem bark contains arjungenin 
and its glycosides, belleric acid, bellericosides. Fruits 
contain hexahydroxydiphenic acid, methyl ester, 
β‐sitosterol, gallic acid, ellagic acid, ethyl gallate, galloyl 
glucose, chebulagic acid, mannitol, glucose, galactose, 
and rhamnose6. T. bellirica bark is mildly diuretic and 
useful in anaemia and leucoderma. Fruits are 
anti‐inflammatory, antihelmintic, expectorant, antipyretic, 
antiemetic and useful in asthma and bronchitis, dropsy, 
dyspepsia, cardiac disorders, skin diseases, leprosy, ulcer. 
Ripe fruits are used as astringent in combination with 
chebulic myrobalan (Terminalia chebula) and 
Phyllanthus emblica as the famous Triphala drug of 
Ayurveda are also useful in eye problems like cataract, 
glaucoma, progressive myopia, and conjunctivitis7. The 
bark of T. bellirica is used as an adulterant to the bark of 
T. arjuna8. The deciduous tree T. bellirica found in 
Southeast Asia is extensively used in traditional Indian 
Ayurvedic medicine for the treatment of hypertension, 
rheumatism and diabetes9. 
Glucosides, tannins, galliacid, ellagic acid, ethyl gallate, 
gallylglucose, chebulanic acid are believed to be mainly 
responsible for its wide therapeutic actions. It has anti-HIV-
1, antimalarial and antifungal activity10. It is used as 
antioxidant, antimicrobial, antidiarrheal, anticancer, 
antidiabetic, antihypertensive and hepatoprotective agent11. 
It also possesses analgesic, antipyretic and anti- ulcerogenic 
effect and antimicrobial activity12-15. 
Research investigations on T. bellirica explored its 
phytochemical and medicinal attributes, but the data 
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available is quite scattered. This review is to 
systematically record the literature available to date 
on phytochemistry, ethnopharmacology, toxicology, 
pharmacological profile and also the tissue cultural 
investigations. 
 
Ecology 
T. bellirica is a large deciduous tree found throughout 
India, in areas up to an altitude of 1,000 m. The tree 
attains a height of 30-40 m. The alternate, broadly 
elliptic leaves are clustered towards the end of the 
branches. They are 10 to 12 cm in length and 7-14 cm in 
breadth. The tree is found in abundance in Madhya 
Pradesh, Uttar Pradesh, Punjab and Maharashtra. It is 
known as vibhitaki, karshaphala and kalidruma in 
Sanskrit. Flowers: small, dirty-grey or greenish-yellow 
with a strong offensive smell, found in axillary spikes. 
Fruits: ovoid, grey, velvety, drupes contain single hard 
stony seed and obscurely 5‐angled when dry. Flowers 
start in March-May and fruits ripen in December-
February. The bark is brownish grey in colour.  
 
Phytoconstituents  
Time-to-time researchers have investigated T. bellirica 
for its many biologically active phytochemicals. They are 
presented in Table 1.  
Table 1 — Phytochemical constituents reported from the Baheda –T. bellirica 
Source Phytochemicals References 
Plant body Beta cetosterol, tannins, gaelic, ethyl and ellagic  acid 16 
 Gallo-tannic acid, Coloring matter, resins and a greenish yellow oil, Tannins, ellagic acid, ethyl gallate, 
galloyl glucose and chebulaginic acid, phenyllemblin, β-sitosterol, mannitol, glucose, fructose and rhamnose 
17 
 Glucoside (bellericanin), Gallo-tannic acid 18 
 Ellagic acid, gallic acid, lignans (termilignan and thannilignan), 7-hydroxy 3’4’ (methylenedioxy) flavone and 
anolignanB  
19 
 Tannins, ellagic acid, ethyl gallate, galloyl glucose and chebulagic acid, phyllemblin, β-sitosterol, mannitol, 
glucose, fructose and rhamnose  
20 
Seed Cardenolide, cannogenol 3-O-D-galactopyranosyl14-O-L-rhamnopyranoside and phospholipids 14. 13 
 Seed contained 12.28 % oil on dry basis; Moisture, ash and crude fibre contents of the seed kernel were found 
to be 8. 43, 2.54, and 8.78 % respectively. The refractive index, co-efficient of viscosity, specific gravity, and 
energy of activation of the oil were found to be 1.28, 403.6 millipoise at 30Â °C, 0.93 and 6.97 Kcal/mole 
respectively; Iodine value, acid value, peroxide value, saponification value, saponification equivalent, ester 
value, unsaponifiable matter, acetyl value, Reichert-Meissel value, Polenske value, free fatty acids as oleic 
acid and cholesterol content of the oil 107, 3.69, 3.14, 189.24, 296.44, 185.55, 1.24 %, 3.78, 0.719, 0.945, 
0.87 % and 26.59 mg per 100 g oil, respectively. ;17.70 % myristic acid, 21.6 % palmitic acid, 45.67 % oleic 
acid and 14.93 % stearic acid.  
21 
Fruit Tain termilignan, thannilignan, 7-hydroxy-3',4'-(methylenedioxy) flavones, anolignan B 5, gallic acid, ellagic 
acid, ß-sitosterol 
22, 23 
 Two new lignans named termilignan and thannilignan, together with 7-hydroxy-3‘,4‘-(methylenedioxy)
flavan and anolignan B  
10 
 Flavonoids, sterols and tannins 14 
 2, 3, 7, 8 -Tetrao xy-chro meno (5,4,3-cde) chro mene-5,10-dione, 24 
 Alkaloid, antraquinone glycoside, saponins, flavonoids, polysaccharides, Steroid, Tannin 8 
 Arjungenin, belleric acid, bellericoside, cannogenol 3-O-dgalactopyranosyl-(1g4)-O-l-rhamnopyranoside 
sitosterol, ethyl gallate, chebulagic acid, galloyl glucose, mannitol, glucose, galactose, fructose and rhamnose 
6, 25 
 Gallic acid, ellagic acid and chebulagic acid 26 
 Gallo-tannic acid and glycoside bellericanin 27 
 Alkaloid, phenol, tannins and flavonoids. 28 
 Glycosides, flavonoids, tannins, phenols, saponin, carbohydrates and proteins. 29 
Stem bark Arjungenin and its glycosides, belleric acid and bellericosides. 13 
 Hydrolysable tannins; gallic acid and ellagic acid in the water-soluble extract 30 
Leaf Proteins, steroids and terpinoids 31 
 Three hydrolysable tannins; gallic acid , ellagic acid and methyl gallate; one flavone; luteolin; two flavonol 
aglycones; quercetine and kaempferol; and four flavonol glycosides; quercetin 3-O-[6"- a-L–
rhamnopyranosyl]-(1g 6)- ß-D- glucopyranoside (rutin,), quercetin-3-O-a-L-rhamnopyranoside,quercetin3-O-
ß-Dglucopyranoside and kaempferol 3-O-ß-D-glucopyranoside 
32 
 Saponins, Tannins, Amino acids, Proteins, Alkaloids, Carbohydrates and Flavonoids. 33 
 4-hydroxy-(2-methylbutanol) benzoic acid 34 
 Pyridine-3-carboxamide,4-dimethylamino-N,2, 4-difluorophenyl β-sitosterol,1,5-diphenyl-3-pentanone, 9-Octadecenoic acid 35 
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Medicinal activities 
In the current era, herbal products are considered to 
be the symbols of safety in comparison to the 
synthetic products that are regarded to be hazardous 
to human life and the environment. So far known 
medicinal potential of T. bellirica is compiled in 
Table 2. 
Anticancer activity 
The studies on the anticancer properties of T. bellirica 
have proved to be a useful asset for preparing a potential 
anticancer drug. In an in vitro experiment carried out to 
know about the anticancer activity of 70 % methanolic 
extract of T. bellirica (TBME) against human breast 
(MCF-7) carcinoma and human lung (A549) carcinoma 
Table 2 — Medicinal Potential of Baheda – T. Bellirica 
Source Observed medicinal potential References 
Plant body Antisecretory and analgesic activities-crude extract inhibited the castor oil-induced intestinal fluid secretion in 
mice at the dose range of 300 - 1000 mg/kg and extract also dose-dependently (50 - 100 mg/kg) reduced the 
numbers of acetic acid-mediated writhes in mice 
36 
Fruit pulp Antidiarrhoeal activity-Aqueous and ethanolic extract of fruit pulp at the doses of 334 mg/kg, 200 mg/kg, 143 
mg/kg showed antidiarrhoeal activity 
37 
Plant body Antihypertensive effect-crude extract of T. bellerica fruit (Tb.Cr) induced a dose-dependent (10-100 mg/kg) fall 
in the arterial BP of rats under anaesthesia. In isolated guinea-pig atria, Tb.Cr inhibited the force and rate of atrial 
contractions. In the rabbit thoracic aorta, Tb.Cr relaxed the phenylephrine (PE, 1 μM) and K+ (80 mM)-induced 
contractions as well as suppressed the PE (1 μM) control peaks in the Ca++-free medium, similar to that caused 
by verapamil. It lowers BP through Ca++ antagonist mechanism and thus provides a sound mechanistic 
background for its medicinal use in hypertension 
14 
Fruits Alcoholic and aqueous extracts of TB showed significant anti salmonella activity 38 
Fruits Elicited relaxation of spontaneous contractions in both isolated rabbit jejunum and guinea-pig ileum, showed a 
protective effect against castor oil-induced diarrhoea and carbachol-mediated bronchoconstriction in rodents, in
the guinea-pig trachea, relaxed the CCh-induced contractions 
39 
Dry fruits Antimicrobial activity-found activity in an aqueous extract of dry fruit against 9 human microbial pathogens @ 4 
mg concentration showed the highest zone of inhibition against S. aureus and dry fruit powder possessed potential 
broad-spectrum antimicrobial activity 
40 
Plant body Ethanolic extract of the plant showed strong activity against Streptococcus mutans 41 
Leaf extract Promising antibacterial activity especially towards Gram-negative bacteria. The inhibitory zone of Escherichia 
coli is 16.3±1.02, 19.0±0.12, 22.6±1.08 in Pseudomonas aureus inhibition of zone is 12.2±0.14, 16.0±1.04, 
23.4±0.06 and for Streptococcus pyrogens, the inhibition is 18.3±1.04, 21.3±0.08, 24.0±1.02 respectively and 
found the zone of inhibition of Streptococcus pyrogens with 400 µg/mL of T. bellirica equal to that of standard 
33 
 The aqueous extract exhibited significant activity against the tested bacteria- E. coli, Pseudomonas aeruginosa, 
Klebsiella pneumonia, Shigella flexneri, and Salmonella typhi and fungal isolates-Aspergillus niger, Mucor 
species, Aspergillus fumigatus, Rhizopus species and Aspergillus flavus, compared with chloroform and petroleum 
ether extract respectively 
28 
 70 % methanol, ethyl acetate, butanol and aqueous extracts showed good antibacterial activity against 
Micrococcus flavus, Staphylococcus aureus and E. coli compared to the antibiotics streptomycin and ampicillin 
32 
Leaf and stem 
powder 
good against Gram-positive bacteria like Corynebacterium rubrum and Staphylococcus epidermidis and Gram-
negative bacteria like Klebsiella pneumonia, E. coli and Salmonella typhimurium. 
42 
Leaf Herbal paste preparation showed significant (p <0.05) improvement in maturation, wound contraction and 
epithelialization, offers a distinctive advantage in wound healing 
43 
 Immunological activity-extract affected T cell proliferation, also affected B cell proliferation through T cell-
independent and T cell-dependent mechanisms respectively. Also found that the extract affected cellular mediated 
immunity (CMI) rather than humoral mediated immunity (HMI) 
19 
Fruits Antidiabetic activity-Hexane, ethylacetate and methanolic extracts of T. bellirica fruit @ 200, 300 and 400 mg/kg, 
p.o for 60 days to Streptozotocin-induced diabetic rats significantly (p <0.05) increased the plasma insulin, 
C-peptide and glucose tolerance levels, body weight, serum total protein, in addition significantly decreased the 
serum levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, urea, uric acid and creatinine in 
diabetic rats 
44 
 Glucose utilization in Vero, L6 and 3T3 cell lines showed that the ethanolic extract was found to be prominent,
Vero, L6 and 3T3 cell lines enhance the glucose uptake by 27.15±1.19, 18.73±1.29 and 24.43±0.88 at 500 µg/mL 
concentration 
45 
(Contd.) 
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and its possible mechanism, the extract showed 
significant cytotoxicity to both A549 and MCF-7 cells, 
while, in non-malignant WI-38 cells, no cytotoxicity was 
found. Flow cytometric analysis of A549 and MCF-7 
carried out by taking 100 μg/mL of TBME as the 
effective concentration inducing apoptosis in the cancer 
cell lines. This concentration of TBME proved to cause 
DNA fragmentation pattern of apoptosis. To know the 
mechanism of apoptosis induction, Nishida et al.54 
performed western blotting in which the ratio of Bax/Bcl-
2 in both A549 and MCF-7 had increased, which in turn 
activated the caspase cascade and the cleavage of PARP. 
These results confirmed the anticancer effects of TBME 
in both lung and breast cancer cell lines by modifying the 
Bcl-2 family proteins54. 
Growth inhibitory activities and synergistic effects 
of P. emblica extract/ doxorubicin or cisplatin and  
T. bellirica extract/ doxorubicin or cisplatin extracts 
showed certain selective effects against A549 and 
HepG2 cells (two cancer cell lines)55. In another 
study, the antimutagenic effect of two polyphenolic 
fractions (TB-3, TB-4) isolated from T. bellirica in 
two strains of S. typhimurium (i.e. TA98 and TA100) 
against NPD (4-nitro-o-phenylenediamine), 2AF  
Table 2 — Medicinal Potential of Baheda – T. Bellirica—(Contd.) 
Source Observed medicinal potential References 
 Administration of T. bellirica fruits against alloxan-induced hyperglycemia and antioxidant defence mechanism in 
rats showed a significant reduction of glucose level and oxidative stress was observed. Increased levels of 
antioxidant enzymes such as superoxide dismutase, glutathione reductase and catalase were observed in blood and 
liver 
46 
 The antioxidant activity-Antioxidant potential of acetone extract/fractions of its fruit was investigated using 
in vitro assays, including scavenging ability against 2,2'-diphenyl-2-picrylhydrazyl (DPPH), β-carotene bleaching 
inhibition, reducing power and chelating ability on Fe2+ ions. Maximum antioxidant activities (expressed as EC50
values) observed were 14.56, 27.81 and 67.8 μg/mL in DPPH, β-carotene bleaching and reducing power assays, 
respectively  
47 
 Crude methanolic extract along with its various organic fractions elicited both in vitro and in vivo antioxidant 
activity as well as antibacterial activity. 
48 
 Antioxidant activity using the DPPH assay indicate that methanolic extracts from Terminalia possess significant 
antioxidant activity at concentrations of 1000-100 µg/mL compared to control 
35 
 Antiulcer activity –Ethanolic extract of T. bellirica at doses of 250,500 mg/kg orally produced significant 
inhibition of the gastric lesions induced by pylorus ligation induced ulcer and ethanol-induced a gastric ulcer. The 
extract (250 mg/kg & 500 mg/kg) showed significant (p <0.05) reduction in free acidity and ulcer index as 
compared to control 
49 
 Methanolic extract of fruits (100, 250, 500, 1000 mg/kg, p.o.) significantly suppressed the peptic ulcer induced by 
ethanol. Methanolic extract at a dose of 500 mg/kg showed, promising antiulcer activity hence, this dose was 
selected for further evaluation of antiulcer studies. The methanolic extract (500 mg/kg) showed significant 
(p <0.05) reduction in gastric volume, free acidity, total acidity, ulcer index, protein and pepsin content and 
increase in mucus content in pylorus-ligated rats as compared to control  
50 
 Delay in clot formation- fruit extract @ 0.20 mg/dL concentration showed maximum delay (more than 90 
minutes) in clot formation 
14 
 Antipyretic activity-ethanolic and aqueous extracts of fruits (200 mg/kg, p.o.) in brewer's yeast-induced fever in 
mice and rats and showed a significant inhibition of elevated body temperature when compared to a 
corresponding control 
51 
Fruits Hepatoprotective activity- evaluated the protective effect of fruit extract and its active principle, gallic acid (3,4,5-
trihydroxybenzoic acid) at different doses against carbon tetrachloride intoxication. Toxicant caused a significant
increase in the activities of serum transaminases and serum alkaline phosphatase. Hepatic lipid peroxidation level 
increased significantly whereas significant depletion was observed in reduced glutathione level after carbon 
tetrachloride administration. A minimum elevation was found in protein content, on the contrary, a significant fall 
was observed in the glycogen content of liver and kidney after toxicant exposure. Activities of adenosine 
triphosphatase and succinic dehydrogenase inhibited significantly in both the organs after toxicity. Treatment with 
extract (200, 400 and 800 mg/kg, p.o.) and gallic acid (50, 100 and 200 mg/kg, p.o.) showed dose-dependent 
recovery but the effect was more pronounced with gallic acid and found to be most effective against carbon 
tetrachloride-induced liver and kidney damage. Treatment with extract (200, 400 and 800 mg/kg, p.o.) and gallic 
acid (50, 100 and 200 mg/kg, p.o.) showed dose-dependent recovery in biochemical parameters such as SGOT, 
SGPT and lipid peroxidase, glutathione but the effect was more pronounced with gallic acid 
52 
Fruit powder Antipsychotic potential-administration of T. bellirica fruit powder in a specially prepared diet for 15 successive 
days in different concentrations (4, 6 and 8 % w/w) showed significant (p <0.05, p <0.01) dose-dependent
potentiating of haloperidol-induced catalepsy. Thus, the results suggest an antidopaminergic activity 
53 
 
KUMAR & KHURANA: A REVIEW OF TERMINALIA BELLIRICA ROXB. 
 
 
101
(2-aminofluorene) and 4NQNO (4-nitroquinoline-N-
oxide) have been distinguished. The researchers found 
that both the compounds were considerably effective 
against S9-dependent 2AF; rather having less striking 
effect against 4-O-nitrophenylenediamine (NPD) but 
almost no effect against 4NQNO in TA100 strain56.  
Antimutagenic potency was observed in water, 
acetone, and chloroform extracts of T. bellirica through 
Ames Salmonella/microsome assay. Acetone extract 
exhibited the variable inhibitory activity of 65.6 and 
69.7 % with 4-O-nitrophenylenediamine (NPD) and 
sodium azide, respectively (as direct-acting mutagens) 
and 81.4 % with 2-aminofluorene (2AF) (an S9-
dependent mutagen), in the preincubation mode of 
experimentation. Inhibition with chloroform and water 
extracts was rather insignificant57. 
The leaf extracts of T. bellirica have promising 
anticancer activity with IC50 of 5.65 µg/mL. 
Phytochemical studies have revealed that T.bellirica 
contains a variety of bioactive ingredients with reported 
therapeutic activities. Methanolic terminalia leaf extracts 
(MTLE) demonstrated a dose-dependent inhibitory 
activity with a certain degree of selectivity against cell 
line Hep G2 cell line. MTLE supplementation down 
regulated expression of Bcl-2, a potent suppressor of 
apoptosis and induced expression of proapoptotic 
proteins Bax, caspase-9 and caspase-3 in a dose-
dependent manner. It also demonstrated that the pro-
apoptotic effect of MTLE was due to down regulation of 
the Akt/mTOR signalling pathway. Flow cytometry 
analysis showed an increase in the percentage of G2/M 
arrest phase in Hep G2 cell line compared to control cell 
line. In summary, the findings demonstrate that MTLE 
treatment of the Hep G2 cells resulted in significant (a) 
cell growth inhibition,(b) G2/M-phase cell cycle arrest, 
and (c) apoptosis in a dose-dependent fashion by 
triggering caspase-9 and caspase-3 activation. Overall, 
these findings suggest that T. bellirica leaves can serve 
as potential therapeutant for the cancer35. 
 
Angiogenesis activity 
Angiogenesis represents an excellent therapeutic 
target for the treatment of cardiovascular diseases. It 
is a potent physiological process that underlies the 
natural manner in which our bodies respond to a 
diminution of blood supply to vital organs, namely the 
production of new collateral vessels to overcome the 
ischemic state. 
Prabhu et al.31 evaluated the angiogenic potential of 
T. bellirica by in vivo mice sponge implantation assay. 
Here, gelatin sponge with or without ethanolic extract 
of T. bellirica leaf (EETB - 0.3 and 0.5 mg, 
respectively) was subcutaneously injected into Swiss 
albino mice and after 14 days the implanted sponges 
were excised and stained section showed that sponge 
containing EETB had produced more vessels in gels 
than sponges alone. The new vessels were abundantly 
filled with intact Red blood corpuscles (RBCs), which 
indicate the formation of a functional vasculature 
inside the sponges and blood circulation in newly 
formed vessels by angiogenesis induced by EETB. 
Haemoglobin in control was nearly 0.3 μg, EETB cases 
the haemoglobin quantity was markedly enhanced to 
about 17 μg. Thus ethanolic extract of T. bellirica leaf 
exhibited a profound angiogenic activity in vivo.  
 
Antidepressant activity  
Dhingra and Valecha58 investigated the effect of 
aqueous and ethanolic extracts of T. bellirica on 
depression in mice using forced swim test (FST) and 
tail suspension test (TST). The extracts were 
administered orally for 10 successive days in separate 
groups of Swiss young male albino mice. Aqueous 
extract (50, 100, and 200 mg/kg) in a dose-dependent 
manner and ethanolic extract (100 mg/kg) 
significantly reduced the immobility time of mice in 
both FST and TST. The extracts had no significant 
effect on the locomotor activity of mice. The 
efficacies of aqueous extract (200 mg/kg) and 
ethanolic extract (100 mg/kg) were found to be 
similar to that of imipramine (15 mg/kg, po) and 
fluoxetine (20 mg/kg, po) administered for 10 
successive days. Both extracts reversed reserpine-
induced extension of immobility period of mice in 
FST and TST. Prazosin (62.5 μg/kg, ip; an alpha1-
adrenoceptor antagonist), sulpiride (50 mg/kg, ip;  
a selective D2 receptor antagonist) and  
p-chlorophenylalanine (100 mg/kg, ip; an inhibitor of 
serotonin synthesis) significantly attenuated the 
aqueous and ethanolic extract-induced antidepressant-
like effect in TST. Thus, both the aqueous and 
ethanolic extracts of T. bellirica elicited a significant 
antidepressant-like effect in mice by interaction with 
adrenergic, dopaminergic and serotonergic systems. 
 
Effects on LDL oxidation and macrophage inflammation 
Tanaka et al.9 investigated the effect of T. bellirica 
extract (TBE) on low-density lipoprotein (LDL) 
oxidation and inflammation in macrophages. TBE 
showed 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical 
scavenging activity and 15-lipoxygenase inhibitory 
activity. TBE also significantly inhibited free radical-
induced LDL oxidation compared to the solvent control 
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in vitro. In THP-1 macrophages, TBE treatment resulted 
in significant decreases of the mRNA expression of 
tumour necrosis factor-alpha (TNF), interleukin-1beta 
(IL-1), and lectin-like oxidized LDL receptor-1 (LOX-
1). TBE also reduced matrix metalloproteinase (MMP)-
9 secretion and intracellular reactive oxygen species 
(ROS) production in THP-1 macrophages. These results 
show that TBE has the inhibitory effects on LDL 
oxidation and macrophage inflammatory response  
in vitro. This suggests that it's in vivo use may inhibit 
atherosclerosis plaque progression. 
 
Anti urolithiatic effect 
Upadhyay et al.59 reported the anti-urolithiatic 
effect of T. bellirica fruits on ethylene glycol-induced 
Renal calculi in albino rats. Renal stone was induced 
in animals by 0.75 % ethylene glycol in drinking 
water for 28 days. The test groups administered with 
methanolic extract of T. bellirica (MeTB) at the doses 
100, 200 and 400 mg/kg b.w. (p.o.) once in a day 
from 15th to 28th day. Cystone (750 mg/kg body 
weight) was used as standard drug. The effect of  
T. bellirica on various physical and biochemical 
parameters in urine as well as in serum was evaluated. 
In vivo antioxidant activity and lithiatic markers were 
estimated in kidney homogenate. The results 
demonstrated that metB (400 mg/kg b.w) significantly 
reduced the ethylene glycol induced disturbance in 
various physical and biochemical parameters in urine 
as well as in serum. metB (400 mg/kg b.w.) prevented 
the depletion of GSH level and decrease in the level 
of SOD in ethylene glycol induced renal injury from 
glycol induced calculi in rats.  
 
Nephrotoxic effects 
Possible protective effects of T. bellerica were 
investigated by Fatima and Sultana60. The rats were 
divided into five groups. The first group served as a 
control and was  injected with the normal saline, 
second group was injected with Gentamicin (80 
mg/kg IP), third group was injected with gentamicin 
plus standard Silymarin 100 mg/kg p.o., the fourth 
and fifth group animals were injected with  
T. bellerica ethanolic and aqueous extracts (500 
mg/kg) plus gentamicin respectively for 15 days. GM-
treated rats showed early kidney dysfunction as serum 
urea, uric acid and creatinine levels increased 
significantly. The significant decrease in GSH levels, 
SOD, CAT activities and increase in TBARS levels, 
indicated that GM-induced nephrotoxicity was 
mediated through oxidative stress reactions. 
histopathological examination of GM treated rats 
revealed degenerative changes in glomeruli tubules. 
Administration of T. bellerica plus gentamicin 
protected kidney tissues against nephrotoxic effects of 
gentamicin as evidenced from amelioration of 
histopathological changes and re-normalization of 
kidney biochemical parameters. 
 
Traditional uses 
The leaves enhance appetite, relieves piles, 
lowering cholesterol and blood pressure, boosts 
immunity and prevents ageing. It also enhances the 
body resistance. It is used as popular and common 
traditional medicine for the above ailments by people 
of Coimbatore district61. 
Fruits are laxative, astringent, anthelmintic and 
antipyretic; also useful in hepatitis, bronchitis, 
asthma, dyspepsia, piles, diarrhoea, coughs, 
hoarseness of voice, eye diseases and scorpion-sting; 
used as a hair tonic. A decoction of the green fruit is 
used for a cough. The pulp of the fruit checks 
dysenteric-diarrhoea, dropsy, piles and leprosy. Seed 
oil is used for relieving pains of rheumatism. The gum 
of the bark is demulcent and purgative. The 
triterpenoid present in the fruits possesses significant 
antimicrobial activity. Kernel oil has purgative action 
and its prolonged use was well tolerated in mice62. 
Seeds are also used as an aphrodisiac, oil extract 
from the seed pulp is used in leucoderma and alopecia. 
Modern investigations have proved the laxative activity 
of the oil20,63. Bibhitaki has astringent qualities and is 
best known for its use in treating all the cough and 
cold-related problems, dental problems, improving 
immunity, digestive, liver and eye problems and for 
fast healing of wounds. The oil from seeds with the 
fruit is well known for its use in treating premature 
greying and also promoting hair growth64. 
 
Dosage and hints for intake 
For a cough, asthma and indigestion: Take equal 
quantities of liquorice root, long pepper and bibhitaki 
(after removing the seed) and powder it as finely as 
possible. Take about 2 tsp of the powder and boil it 
along with 500 mL of water till it reduces to about 
300 mL. Drink about 100 mL of this decoction twice 
a day (morning and evening). This remedy will give 
good relief from indigestion, asthma and cough.; For 
a sore throat: Take one broken shell of the fruit and 
suck on it, it works as an astringent having bitter taste 
but relieves for a sore throat and cough.; For wounds: 
Bibhitaki fruit shell paste is an amazing wound healer. 
Very useful for minor rashes and skin irritations. For 
paste preparation, take a small piece of bibhitaki and 
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rub it on a stone (sandalwood stone) along with small 
amount of water to get a smooth paste; for dental 
problems: decoction made by boiling the shell of the 
broken fruit along with 50-75 mL water and rinse the 
mouth. It takes care of most of the dental problems 
also the mouth odour, ulcers, etc.; Natural tonic: Pure 
bibhitaki shell powder can be used instead of the 
bibhitaki fruit. Bibhitaki powder when mixed with 
honey acts a natural tonic and applied as a warm 
water poultice it gives quick relief of minor skin 
irritations. 
 
Micropropagation: Tissue culture investigations  
Commercial exploitation of T. bellerica by various 
industries along with losses due to indiscriminate 
felling of trees, conversion of forest land into 
agriculture land and human settlements have all led to 
rapid depletion of its genetic resources. There is an 
increasing need for the conservation of these plants 
through systematic cultivation for maintaining 
germplasm for selection of desired genotypes and 
mass propagation of the superior clones. Conventional 
methods of T. bellerica propagation are insufficient 
because of poor seed germination and low survival 
rates of stem cuttings66. Therefore, alternative, rapid 
propagation of selected tree stocks is needed.  
A protocol for micropropagation of plants via 
axillary bud proliferation from nodal explants of  
T. bellirica seedlings has been established. Explants 
can be cultured on Murashige and Skoog (MS) 
medium with different concentrations of 6-
benzyladenine or kinetin. Within the range evaluated, 
the medium containing 13.3 μm BA showed the 
highest shoot length (1.9= 0.2 cm) in the primary 
culture. When separated and transferred to fresh 
subculturing medium with lower levels of BA or Kn, 
the nodal segments from individual regenerants showed 
efficient shoot induction at 4.4 μm BA67. Rathore et al.68 
used nodal segments obtained from 15 days old 
aseptically grown seedling as explants. MS medium 
containing 1.5 mg/LBAP was found suitable for culture 
initiation. Best rooting response (60 %) was observed on 
medium containing quarter strength MS salts, 0.6 % 
agar and 0.1 mg/L IBA. 
Phulwaria et al.69 found MS medium containing 
2.22 μm BAP to be the best for shoot multiplication in a 
single step. After excision of newly formed shoots, 
mother explants successively transferred to the same 
medium produced maximum number of shoots per 
explant. Further enhancement in morphogenetic 
response occurred when excised shoot clumps (2–3 
shoots) were subcultured on MS medium supplemented 
with 2.22 μM BAP, 1.16 μM Kn and 0.57 μM IAA. 
Half-strength MS medium supplemented with 24.60 μM 
IBA and 100 mg/L AC was most effective for rooting of 
the shoots. To reduce labour, cost and time, an 
experiment on ex vitro rooting was also carried out and 
it was observed that highest per cent shoots rooted  
ex vitro when treated with 2,460 μM IBA for 5 minutes.  
Rapid in vitro micropropagation was also achieved 
using nodal explants from a mature tree on MS medium 
supplemented with 0.5 mg/L 6-benzylaminopurine 
showed 100 % shoot-bud with 4.5±0.56 cm shoot length 
per explant. The nodal segments from micro shoots 
obtained from induction medium were cultured on MS 
basal medium supplemented with different 
concentrations of BAP and NAA. Best shoot 
multiplication occurred with 0.25 mg/L BAP + 0.25 
mg/L NAA. The shoot and node number increased 
significantly in the third and fourth subculture of nodal 
segments. Excised shoots (2-3 cm long with 2 to 3 
nodes), when grown on half MS basal medium with 0.25 
mg/L with indole-3-butyric acid (IBA), has shown 
rhizogenesis. After four-weeks, plants were transferred 
from greenhouse to net house where the plants exhibited 
gradual acclimatization to outdoor conditions70. 
Dhaker et al.71 found MS medium containing 2.0 
mg/L BAP was most suitable for culture initiation. 
Although shoot multiplication was achieved on MS 
medium containing BAP and Kn, the maximum number 
of shoots was obtained with 3.5 mg/L BAP + 0.5 mg/L 
Kn. Best rooting was observed on medium containing 
quarter strength MS salts, 0.8 % agar and 1.0 mg/L IBA. 
Maximum callus induction was observed on MS 
medium supplemented with 0.25 mg/L 2,4-D+ 0.3 mg/L 
Kn within 4 weeks from leaf petiole. 
Another study reported an efficient in vitro 
micropropagation protocol from nodal segments of a 30-
year-old tree. Nodal segments were taken from the 
mature tree in March-April and cultured on half strength 
MS medium. The highest multiplication of shoots was 
achieved on medium supplemented with  
6-benzyladenine (BA, 8.8 μM) and α-naphthalene acetic 
acid (NAA, 2.6 μM)72. 
 
Genetic diversity of T. bellirica 
Dangi et al.73 studied genetic diversity in T. bellirica 
based on morphological, phytochemical and molecular 
markers from 28 accessions belonging to 4 
ecogeographic regions. Significant differences were 
observed for morphological descriptors viz., leaf type, 
fruit shape and plant nature. UPGMA dendrogram for 
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morphochemical traits clustered the accessions into three 
groups. Molecular diversity was studied using RAPD 
and ISSR markers. A total of 19 polymorphic primers 
(15 RAPD and 4 ISSR) produced 55 polymorphic bands 
with an average of 5.8 bands per primer. At 59 % 
similarity UPGMA derived dendrogram divided the 
populations into clusters based on geographical 
distribution. High genetic differentiation (GST = 0.63) 
was found among the populations with restricted gene 
flow (Nm= 0.26). 
Genetic diversity was assessed within each 
population, among the populations and also in micro 
propagated plantlets of T. bellirica using random 
amplification amplified polymorphic DNA (RAPD) 
marker in plants collected from four different districts of 
Chhattisgarh State, India and ten from in vitro produced 
plantlets using Twenty primers for RAPD analysis. 
RAPD analysis which yielded 168 bands of which 152 
polymorphic bands (90 % polymorphism), revealing a 
very high level of genetic diversity in the species74. 
 
Cytological studies 
The cytological observations revealed that mother 
tincture of T.bellerica had a strong mitostatic effect 
on Vicia faba root as evident by the mitotic index 
which decreases with the increases in duration from 4 
to 12 hours and concentration from 5 to 50 % in the 
test plant. The reduction in mitotic index might be due 
to physiological changes induced by the drug in 
nuclear chromatin and chromosomal anomalies27. 
 
Toxicity studies 
Thanabhorn et al.75 evaluated acute and subacute 
toxicities of the ethanol extract from T. bellirica. A 
single oral administration of the ethanol extract  
@ 5,000 mg/kg did not cause toxicity, behavioural 
changes, mortality and differences on gross appearance 
of internal organs. For the subacute toxicity, all rats 
received a repeated oral dose of 1,000 mg/kg of the 
ethanol extract over 14 days. The satellite group was 
given the ethanol extract in the same period but kept 
for further 14 days without medication to detect the 
delayed effects or reversibility of toxic effects. The 
results showed that the extract did not cause any 
changes in terms of general behaviour, mortality, 
weight gain, haematological or clinical blood chemistry 
parameters. The histological examinations showed the 
normal appearance of the internal organs very 
comparable to the control group. 
Sireeratawong et al.76 assessed acute and chronic 
toxicities of the water extract from the dried fruits of  
T. bellerica in both female and male rats. For acute 
toxicity, a single oral administration of the water 
extract @5,000 mg/kg body weight (10 female,  
10 male) was given. No toxicity (such as general 
behaviour changes, morbidity, mortality, changes in 
gross appearance or histopathological changes of the 
internal organs of rats) was seen. The study of chronic 
toxicity was determined by oral feeding both female 
and male rats (10 female, 10 male) daily with the test 
substance @3 00, 600 and 1,200 mg/kg body weight 
continuously for 270 days. Repeated examinations for 
signs of toxicity showed no abnormalities in the test 
groups as compared to the controls. 
Acute administration of aqueous acetone extract of 
T. bellirica fruits (AATB) was done in female Wistar 
albino rats as a single dose up to 2000 mg/kg body 
weight. In the end, blood was collected for biochemical 
and haematological analyses, while histological 
examinations were performed on liver and kidney. 
There was no alteration in the behavioural pattern, food 
and water intake in the treated animals. The relative 
organ weight, biochemical parameters, haematological 
parameters and histopathological analysis were also 
just like the normal. All the parameters for toxicity 
evaluation suggest that aqueous acetone extract of  
T. bellirica fruit is safe, to be used as a traditional 
herbal formulation for its antioxidant potential and 
other health benefits77. Kuriakose78 suggested that its 
therapeutic potential is helpful in alleviating hepatic 
oxidative stress and tissue damage, hence the 
traditional use of the plant in this regard stands 
justified. 
 
Conclusion 
An updated literature survey revealed that  
T. bellirica has a diverse pharmacological spectrum. 
This has been used in Ayurveda, Siddha, Chinese 
medicine etc, because of having important 
phytoconstituents viz., Gallo-tannic acid, bellericanin, 
ellagic acid, gallic acid, termilignan, thanni lignan, 
flavone and anolignan B, Tannins, ellagic acid, ethyl 
gallate, galloyl glucose and chebulaginic acid, 
phenyllemblin, - sitosterol, mannitol, glucose, fructose 
and rhamnose. Because of these compounds, it shows 
many of the pharmacological activities such as 
antisecretory, analgesic, antihypertensive, antidiarrhoeal 
activity, antimicrobial activity, antidiabetic, antioxidant, 
antiulcer, antipyretic, hepatoprotective, anticancer, 
angiogenesis, antidepressant-like activity. It is anti-
urolithiatic. It is useful in the treatment of gastric ulcer, 
constipation, general debility, piles etc. still, it has 
actually not been explored comprehensively. Thus it 
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needs to be explored the potent phytoconstituents from 
the plant having valuable pharmacological properties for 
new high-quality drug formulations. 
T. bellirica has the antibacterial potential to derive 
novel antimicrobial agents for the treatment of various 
infections for developing new medicines. It can be 
exploited differentially by the pharmaceutical industry. 
It has antioxidant potential and many health benefits. 
The extracts of T. bellirica also has promising anticancer 
ingredients but the promising active principles and the 
underlying mechanism by which there is such activity in 
T. bellirica needs to be further investigated. T. bellirica 
is a promising angiogenic agent. T. bellirica and also 
have a nephroprotective effect. It can prevent the 
deposition of CaOx crystal in the kidney. 
The seedling derived explants have been used for 
micropropagation as they are easy to establish in culture. 
In T. bellerica, MS medium containing 1.5 mg/L-2.0 
mg/L BAP was the best for culture initiation while 1-2.0 
mg/L BAP was most suitable for shoot multiplication. 
Best shooting response was observed on media 
containing BAP and IBA (Auxin) and widely used for 
root induction hormone. T. bellirica genotypes revealed 
a high level of RAPD variations in the population. 
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